Company Performance: Revenue, profit margins, and overall financial health directly impact investor confidence and stock value.

Industry Trends: The overall health and growth prospects of the pharmaceutical industry influence stock performance.

Regulatory Environment: Changes in drug regulations, pricing policies, and healthcare reforms can significantly affect profitability.

Market Sentiment: General investor optimism or pessimism towards the stock market and specific sectors can drive price fluctuations.

Competitive Landscape: The presence of competing drugs and the entry of new players in the market affect market share and profitability.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and economic growth can impact investor behavior and stock valuations.

Global Events: Geopolitical events, trade policies, and global health crises can create volatility and impact stock prices.

Company News: Announcements about drug approvals, clinical trial results, partnerships, and acquisitions can trigger immediate price changes.

Analyst Ratings: Recommendations from financial analysts can influence investor perception and trading activity.

Dividend Policy: Dividend payouts and dividend yield can attract income-seeking investors and support stock value.

Shareholder Structure: The concentration of ownership and the presence of institutional investors can affect trading dynamics and price stability.

Technological Innovation: Advancements in drug discovery and development can boost investor confidence and drive stock appreciation.